Description
Tesofensine is a reuptake inhibitor that increases the availability of serotonin, noradrenaline, and dopamine in the brain. It functions by inhibiting the neurotransmitters in the brain associated with hunger and appetite.
Tesofensine is being studied extensively to see if it could be used to treat neurological conditions such as Parkinson’s and ADHD. In animal trials, effects on motor function and cognitive function improved in the respective disease models. From these trials, the subject models began to lose too much weight, and now researchers are determining its potential to treat obesity. Several clinical trials have been done to show its promising potential to treat obesity and it has since been in phase II trials.